360 filings
8-K
VRDN
Viridian Therapeutics Inc
20 Jun 24
Departure of Directors or Certain Officers
4:16pm
DEFA14A
VRDN
Viridian Therapeutics Inc
10 Jun 24
Additional proxy soliciting materials
8:05am
10-Q
2024 Q1
VRDN
Viridian Therapeutics Inc
Quarterly report
8 May 24
7:51am
8-K
VRDN
Viridian Therapeutics Inc
8 May 24
Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
7:09am
ARS
2023 FY
VRDN
Viridian Therapeutics Inc
26 Apr 24
Annual report to shareholders
8:34am
DEFA14A
8r7pnym6uf
26 Apr 24
Additional proxy soliciting materials
8:32am
8-K
tbxiqppleorgtve6m
16 Apr 24
Entry into a Material Definitive Agreement
4:06pm
S-8
li67rxk7
28 Feb 24
Registration of securities for employees
4:10pm
8-K
s8bl8k
27 Feb 24
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
4:07pm
8-K
b65hbctku4jach
19 Jan 24
Entry into a Material Definitive Agreement
5:22pm
424B5
wzigc
19 Jan 24
Prospectus supplement for primary offering
4:32pm
424B5
t4gil4u1ts
17 Jan 24
Prospectus supplement for primary offering
4:04pm
8-K
lvqjkk5f7to
8 Jan 24
Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference
8:08am
8-K
veptpil mul89u
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
8:15am
S-3ASR
t9cas3lbs
30 Nov 23
Automatic shelf registration
4:05pm
8-K
hhs4qy2m jj04ur
13 Nov 23
Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:06pm
8-K
hkh3qk
2 Nov 23
Departure of Directors or Certain Officers
4:31pm